Literature DB >> 18624399

A mouse model repository for cancer biomarker discovery.

Karen S Kelly-Spratt1, A Erik Kasarda, Mark Igra, Christopher J Kemp.   

Abstract

Early detection of cancer using biomarkers obtained from blood or other easily accessible tissues would have a significant impact on reducing cancer mortality. However, identifying new blood-based biomarkers has been hindered by the dynamic complexity of the human plasma proteome, confounded by genetic and environmental variability, and the scarcity of high quality controlled samples. In this report, we discuss a new paradigm for biomarker discovery through the use of mouse models. Inbred mouse models of cancer recapitulate many critical features of human cancer, while eliminating sources of environmental and genetic variability. The ability to collect samples from highly matched cases and controls under identical conditions further reduces variability which is critical for successful biomarker discovery. We describe the establishment of a repository containing tumor, plasma, urine, and other tissues from 10 different mouse models of human cancer, including two breast, two lung, two prostate, two gastrointestinal, one ovarian, and one skin tumor model. We present the overall design of this resource and its potential use by the research community for biomarker discovery.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18624399      PMCID: PMC3727967          DOI: 10.1021/pr800210b

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  36 in total

1.  Early detection cancer research network.

Authors:  S Srivastava; B S Kramer
Journal:  Lab Invest       Date:  2000-08       Impact factor: 5.662

Review 2.  The case for early detection.

Authors:  Ruth Etzioni; Nicole Urban; Scott Ramsey; Martin McIntosh; Stephen Schwartz; Brian Reid; Jerald Radich; Garnet Anderson; Leland Hartwell
Journal:  Nat Rev Cancer       Date:  2003-04       Impact factor: 60.716

Review 3.  The human plasma proteome: history, character, and diagnostic prospects.

Authors:  N Leigh Anderson; Norman G Anderson
Journal:  Mol Cell Proteomics       Date:  2002-11       Impact factor: 5.911

Review 4.  Proteomic applications for the early detection of cancer.

Authors:  Julia D Wulfkuhle; Lance A Liotta; Emanuel F Petricoin
Journal:  Nat Rev Cancer       Date:  2003-04       Impact factor: 60.716

5.  Female mice chimeric for expression of the simian virus 40 TAg under control of the MISIIR promoter develop epithelial ovarian cancer.

Authors:  Denise C Connolly; Rudi Bao; Alexander Yu Nikitin; Kasie C Stephens; Timothy W Poole; Xiang Hua; Skye S Harris; Barbara C Vanderhyden; Thomas C Hamilton
Journal:  Cancer Res       Date:  2003-03-15       Impact factor: 12.701

6.  Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends.

Authors:  Ruth Etzioni; David F Penson; Julie M Legler; Dante di Tommaso; Rob Boer; Peter H Gann; Eric J Feuer
Journal:  J Natl Cancer Inst       Date:  2002-07-03       Impact factor: 13.506

7.  Conditional activation of Neu in the mammary epithelium of transgenic mice results in reversible pulmonary metastasis.

Authors:  Susan E Moody; Christopher J Sarkisian; Kristina T Hahn; Edward J Gunther; Steven Pickup; Katherine D Dugan; Nathalie Innocent; Robert D Cardiff; Mitchell D Schnall; Lewis A Chodosh
Journal:  Cancer Cell       Date:  2002-12       Impact factor: 31.743

8.  Pathobiology of autochthonous prostate cancer in a pre-clinical transgenic mouse model.

Authors:  Paula J Kaplan-Lefko; Tsuey-Ming Chen; Michael M Ittmann; Roberto J Barrios; Gustavo E Ayala; Wendy J Huss; Lisette A Maddison; Barbara A Foster; Norman M Greenberg
Journal:  Prostate       Date:  2003-05-15       Impact factor: 4.104

9.  Plasma proteome profiling of a mouse model of breast cancer identifies a set of up-regulated proteins in common with human breast cancer cells.

Authors:  Sharon J Pitteri; Vitor M Faca; Karen S Kelly-Spratt; A Erik Kasarda; Hong Wang; Qing Zhang; Lisa Newcomb; Alexei Krasnoselsky; Sophie Paczesny; Gina Choi; Matthew Fitzgibbon; Martin W McIntosh; Christopher J Kemp; Samir M Hanash
Journal:  J Proteome Res       Date:  2008-02-27       Impact factor: 4.466

10.  Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer.

Authors:  Shunyou Wang; Jing Gao; Qunying Lei; Nora Rozengurt; Colin Pritchard; Jing Jiao; George V Thomas; Gang Li; Pradip Roy-Burman; Peter S Nelson; Xin Liu; Hong Wu
Journal:  Cancer Cell       Date:  2003-09       Impact factor: 31.743

View more
  10 in total

Review 1.  Integrating high-throughput technologies in the quest for effective biomarkers for ovarian cancer.

Authors:  Vathany Kulasingam; Maria P Pavlou; Eleftherios P Diamandis
Journal:  Nat Rev Cancer       Date:  2010-04-12       Impact factor: 60.716

2.  Pyranocoumarin Tissue Distribution, Plasma Metabolome and Prostate Transcriptome Impacts of Sub-Chronic Exposure to Korean Angelica Supplement in Mice.

Authors:  Jinhui Zhang; Li Li; Suni Tang; Yong Zhang; Maciej Markiewski; Chengguo Xing; Cheng Jiang; Junxuan Lü
Journal:  Am J Chin Med       Date:  2016       Impact factor: 4.667

3.  Proteome and transcriptome profiles of a Her2/Neu-driven mouse model of breast cancer.

Authors:  Regine M Schoenherr; Karen S Kelly-Spratt; ChenWei Lin; Jeffrey R Whiteaker; Tao Liu; Ted Holzman; Ilsa Coleman; Li-Chia Feng; Travis D Lorentzen; Alexei L Krasnoselsky; Pei Wang; Yan Liu; Kay E Gurley; Lynn M Amon; Athena A Schepmoes; Ronald J Moore; David G Camp; Lewis A Chodosh; Richard D Smith; Peter S Nelson; Martin W McIntosh; Christopher J Kemp; Amanda G Paulovich
Journal:  Proteomics Clin Appl       Date:  2011-02-15       Impact factor: 3.494

4.  Tumor microenvironment-derived proteins dominate the plasma proteome response during breast cancer induction and progression.

Authors:  Sharon J Pitteri; Karen S Kelly-Spratt; Kay E Gurley; Jacob Kennedy; Tina Busald Buson; Alice Chin; Hong Wang; Qing Zhang; Chee-Hong Wong; Lewis A Chodosh; Peter S Nelson; Samir M Hanash; Christopher J Kemp
Journal:  Cancer Res       Date:  2011-06-08       Impact factor: 12.701

Review 5.  Early detection of breast cancer: new biomarker tests on the horizon?

Authors:  Aparna C Jotwani; Julie R Gralow
Journal:  Mol Diagn Ther       Date:  2009-12-01       Impact factor: 4.074

6.  A maximum Likelihood Approach to Analyzing Incomplete Longitudinal Data in Mammary Tumor Development Experiments with Mice.

Authors:  Jihnhee Yu; Albert Vexler; Alan D Hutson
Journal:  Sri Lankan J Appl Stat       Date:  2013-01-09

7.  Mouse-specific tandem IgY7-SuperMix immunoaffinity separations for improved LC-MS/MS coverage of the plasma proteome.

Authors:  Jian-Ying Zhou; Brianne O Petritis; Konstantinos Petritis; Angela D Norbeck; Karl K Weitz; Ronald J Moore; David G Camp; Rohit N Kulkarni; Richard D Smith; Wei-Jun Qian
Journal:  J Proteome Res       Date:  2009-11       Impact factor: 4.466

8.  Plasma proteome profiles associated with inflammation, angiogenesis, and cancer.

Authors:  Karen S Kelly-Spratt; Sharon J Pitteri; Kay E Gurley; Denny Liggitt; Alice Chin; Jacob Kennedy; Chee-Hong Wong; Qing Zhang; Tina Busald Buson; Hong Wang; Samir M Hanash; Christopher J Kemp
Journal:  PLoS One       Date:  2011-05-12       Impact factor: 3.240

9.  Serial analysis of 38 proteins during the progression of human breast tumor in mice using an antibody colocalization microarray.

Authors:  Huiyan Li; Sébastien Bergeron; Matthew G Annis; Peter M Siegel; David Juncker
Journal:  Mol Cell Proteomics       Date:  2015-02-13       Impact factor: 5.911

10.  Serum S100A6 concentration predicts peritoneal tumor burden in mice with epithelial ovarian cancer and is associated with advanced stage in patients.

Authors:  Bih-Rong Wei; Shelley B Hoover; Mark M Ross; Weidong Zhou; Francesco Meani; Jennifer B Edwards; Elizabeth I Spehalski; John I Risinger; W Gregory Alvord; Octavio A Quiñones; Claudio Belluco; Luca Martella; Elio Campagnutta; Antonella Ravaggi; Ren-Ming Dai; Paul K Goldsmith; Kevin D Woolard; Sergio Pecorelli; Lance A Liotta; Emanuel F Petricoin; R Mark Simpson
Journal:  PLoS One       Date:  2009-10-30       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.